Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GBP2 |
| Upstream (Parents) |
|---|
| (<<) ADCY7 → GBP2 |
| (<<) CLEC2B → GBP2 |
| (<<) HIF1A → GBP2 |
| (<<) HLA-F → GBP2 |
| (<<) ICAM1 → GBP2 |
| (<<) JUNB → GBP2 |
| (<<) KCTD12 → GBP2 |
| (<<) KLF2 → GBP2 |
| (<<) LPXN → GBP2 |
| (<<) PIK3CD → GBP2 |
| (<<) PIP4K2A → GBP2 |
| (<<) PRKCB → GBP2 |
| (<<) STAT4 → GBP2 |
| (<<) UBE2L6 → GBP2 |
| Downstream (Children) |
|---|
| GBP2 → ATXN1 (>>) |
| GBP2 → CASP1 (>>) |
| GBP2 → CSF2 (>>) |
| GBP2 → FGFR3 (>>) |
| GBP2 → FOXA2 (>>) |
| GBP2 → HLA-G (>>) |
| GBP2 → HSPC159 (>>) |
| GBP2 → IRF1 (>>) |
| GBP2 → MAPK11 (>>) |
| GBP2 → MYL7 (>>) |
| GBP2 → PLA2G3 (>>) |
| GBP2 → PLA2G4A (>>) |
| GBP2 → PPP3CB (>>) |
| GBP2 → PTAFR (>>) |
| GBP2 → RAC2 (>>) |
| GBP2 → STAT5A (>>) |
| GBP2 → TYRO3 (>>) |
| GBP2 → VAV1 (>>) |
| GBP2 → ZBED2 (>>) |
